Reversibility of human myopathy caused by vitamin E deficiency
about
Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanismEffects of vitamin E on cognitive performance during ageing and in Alzheimer's diseaseArrest of neuropathy and myopathy in abetalipoproteinemia with high-dose vitamin E therapyReversible inflammatory and vacuolar myopathy with vitamin E deficiency in celiac disease.Neuromuscular diseases and disorders of the alimentary system.Etiologic factors and pathologic alterations in selenium-vitamin E deficiency and excess in animals and humans.Promotion of plasma membrane repair by vitamin E.Neurologic complications after surgery for obesity.Absence of Dystrophin Disrupts Skeletal Muscle Signaling: Roles of Ca2+, Reactive Oxygen Species, and Nitric Oxide in the Development of Muscular Dystrophy.Vitamin and mineral deficiencies in the developed world and their effect on the eye and vision.Liver Transplantation as a Treatment for Severe Refractory Vitamin E Deficiency Related to Progressive Familial Intrahepatic Cholestasis Type 2 in a Pediatric Patient.Progressive neuromuscular disease in children with chronic cholestasis and vitamin E deficiency: clinical and muscle biopsy findings and treatment with alpha-tocopherol.Oxidative status and histological changes in sea bass larvae muscle in response to high dietary content of docosahexaenoic acid DHA.Kinetics of tissue alpha-tocopherol uptake and depletion following administration of high levels of vitamin E.Physiological and therapeutic role of vitamin E in humans: an update.
P2860
Q24603957-3A4028D1-BFDF-46A1-9E27-ECA6B4157AF7Q26864433-596E1FB7-B4B8-4D24-8B14-080A00DBEF96Q34300619-13F69804-FCB4-4CA6-BE89-00CEC25E3A5BQ34351435-150540A2-3BFC-4C90-8190-3B7A8C2C0AAEQ34737044-725210DE-EC0A-424E-B47A-9684DB7A28B2Q35330127-10BC1A6E-23D6-4F33-9D30-607720485463Q35639232-8298BFD1-B61F-41E7-A910-408E56EB86E9Q36171942-7DDDCC55-9489-46EB-A53E-B68EF35F43E0Q36422465-0C0905AE-9208-454B-ABCE-52DE31CDE257Q37059147-0D28DE63-4DA6-46AA-B20A-B7A03609E89CQ41241205-E76B6381-0588-4DCB-994B-92B27E61DDFFQ42261573-E6E63B2E-EED5-485B-86FA-6BCD7F2A7674Q45778449-9FCD0AC2-436E-4639-8261-A03774614B0EQ49080089-A6DB1528-BC5A-4064-858D-CB6C476DF613Q53907450-9EEDDD2E-27DB-4E2D-8668-A84F3CC4C4E8
P2860
Reversibility of human myopathy caused by vitamin E deficiency
description
1979 nî lūn-bûn
@nan
1979 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Reversibility of human myopathy caused by vitamin E deficiency
@ast
Reversibility of human myopathy caused by vitamin E deficiency
@en
Reversibility of human myopathy caused by vitamin E deficiency
@nl
type
label
Reversibility of human myopathy caused by vitamin E deficiency
@ast
Reversibility of human myopathy caused by vitamin E deficiency
@en
Reversibility of human myopathy caused by vitamin E deficiency
@nl
prefLabel
Reversibility of human myopathy caused by vitamin E deficiency
@ast
Reversibility of human myopathy caused by vitamin E deficiency
@en
Reversibility of human myopathy caused by vitamin E deficiency
@nl
P3181
P356
P1433
P1476
Reversibility of human myopathy caused by vitamin E deficiency
@en
P2093
L G Tomasi
P304
P3181
P356
10.1212/WNL.29.8.1182
P407
P577
1979-08-01T00:00:00Z